BETA
Start SIP
Invest Now
Start SIP in BETA
Performance
- Low
- ₹1,525
- High
- ₹1,600
- 52 Week Low
- ₹1,430
- 52 Week High
- ₹2,046
- Open Price₹1,599
- Previous Close₹1,590
- Volume4,604
Investment Returns
- Over 1 Month -6.35%
- Over 3 Month -14.23%
- Over 6 Month -11.94%
- Over 1 Year -19.21%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 1,569
- P/B Ratio
- 7.1
- Average True Range
- 70.08
- EPS
- 45.36
- Dividend Yield
- 0
- MACD Signal
- -31.81
- RSI
- 39.21
- MFI
- 18.71
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,554.20
-36.1
(-2.27%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,613.44
- 50 Day
- ₹1,671.03
- 100 Day
- ₹1,718.59
- 200 Day
- ₹1,732.37
Resistance and Support
1559.83
- R3 1,669.97
- R2 1,635.13
- R1 1,594.67
- S1 1,519.37
- S2 1,484.53
- S3 1,444.07
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-06 | Quarterly Results | |
| 2025-05-15 | Audited Results | |
| 2025-03-27 | Others | To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2025-02-05 | Issue of Bonus & Others | To consider other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2024-11-06 | Quarterly Results |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,554 As on 27 December, 2025 | 20:22
The Market Cap of Beta Drugs is ₹1568.9 Cr As on 27 December, 2025 | 20:22
The P/E ratio of Beta Drugs is As on 27 December, 2025 | 20:22
The PB ratio of Beta Drugs is 7.1 As on 27 December, 2025 | 20:22
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.